Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HK1 | P19367 | 4/20 | 0.58 |
| ▸ | HK2 | P52789 | 4/20 | 0.58 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.48 |
| ▸ | HRAS | P01112 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10521162 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL12812847 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL374488 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL9746872 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL18803484 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL14780667 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL10522400 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL15763312 | 1.00 | HK1 (0.58) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL11073387 | 0.89 | ALDH1A1 (0.53) | HK1HK2LGALS8HRASALDH1A1 | |
| SCHEMBL22604145 | 0.88 | LGALS8 (0.49) | HK1HK2LGALS8HRASALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026085839-A1 | COMPOSITION AND METHOD FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2026-04-30 | — | — | WO | claimed |
| WO-2026085839-A1 | COMPOSITION AND METHOD FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2026-04-30 | — | — | WO | disclosed |
| CN-113666980-B | High-selectivity Xa factor inhibitor heparin heptasaccharide and preparation method and application thereof | 山东大学 | 2023-12-26 | — | — | CN | disclosed |
| WO-2013091660-A1 | A METHOD FOR OBTAINING CRYSTALLINE LACTO-N-TETRAOSE AND LACTO-N-NEOTETRAOSE PRECURSORS AND MIXTURES THEREOF | GLYCOM A/S (DK) | 2013-06-27 | — | — | WO | disclosed |
| US-6562514-B1 | Stabilized vanadium electrolyte solutions for all-vanadium redox cells and batteries | PINNACLE VRB LIMITED (AU) | 2003-05-13 | — | — | US | disclosed |
| US-6468688-B2 | CHARGING, DISCHARGING EFFICIENCY; VANADIUM ELECTROLYTE | PINNACLE VRB LIMITED (AU) | 2002-10-22 | — | — | US | disclosed |
| US-20010028977-A1 | Charging, discharging efficiency; vanadium electrolyte | JD HOLDING INC. (KY) | 2001-10-11 | — | — | US | disclosed |
| US-6143443-A | ALL-VANADIUM REDOX BATTERY, COMPRISING THE STABILIZED ELECTROLYTE | PINNACLE ARB LIMITED (AU) | 2000-11-07 | — | — | US | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
| EP-0206037-B1 | CARBAMATES AND UREAS OF N-(2-AMINOACYLAMIDO-2-DESOXY-HEXOSYL) AMIDE, METHOD FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | BAYER AG (DE) | 1992-01-15 | — | — | EP | disclosed |
| US-4855283-A | IMMUNE SYSTEM STIMULANTS | BAYER AKTIENGESELLSCHAFT (DE) | 1989-08-08 | — | — | US | disclosed |
| EP-0206037-A2 | Carbamates and ureas of N-(2-aminoacylamido-2-desoxy-hexosyl) amide, method for their preparation and their pharmaceutical use | BAYER AG (DE) | 1986-12-30 | — | — | EP | disclosed |
| EP-0155625-A2 | Glycolipid-like substances in liposome form | BAYER AG (DE) | 1985-09-25 | — | — | EP | disclosed |